Screening of genes encoding junctional candidates in arrhythmogenic right ventricular cardiomyopathy/dysplasia

Europace

Volumn 15, Issue 10, 2013, Pages 1522-1525

  Gandjbakhch, Estelle ^a,b   Vite, Alexia ^a   Gary, Françoise ^a   Fressart, Véronique ^b   Donal, Erwan ^c   Simon, Françoise ^b   Hidden Lucet, Françoise ^a,b   Komajda, Michel ^a,b   Charron, Philippe ^a,b   Villard, Eric ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy dysplasia; Candidate gene analysis; Cardiomyopathy; Desmosomes; Genetics; Mutation

Indexed keywords

CAVEOLIN 1; PHOSPHOLAMBAN; PLAKOPHILIN;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T WAVE INVERSION;

ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY/DYSPLASIA; CANDIDATE GENE ANALYSIS; CARDIOMYOPATHY; DESMOSOMES; GENETICS; MUTATION;

AMINO ACID SEQUENCE; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PLAKOPHILINS;

EID: 84885017079     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut224     Document Type: Article

References (29)

1. Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 2010;61:233-53.
2. Hulot J-S, Jouven X, Empana J-P, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation 2004;110:1879-84.
3. Gerull B, Heuser A, WichterT, Paul M, BassonCT,McDermottDAet al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-4.
4. Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon A et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 2006;113:1171-9.
5. Syrris P, Ward D, Evans A, Asimaki A, Gandjbakhch E, Sen-Chowdhry S et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet 2006;79:978-84.
6. NormanM, Simpson M, Mogensen J, Shaw A, Hughes S, Syrris P et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 2005;112:636-42.
7. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
8. Fressart V, Duthoit G, Donal E, Probst V, Deharo J-C, Chevalier P et al. Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace 2010;12:861-8.
9. Christensen AH, Andersen CB, Tybjærg-Hansen A, Haunso S, Svendsen JH. Mutation analysis and evaluation of the cardiac localization of TMEM43in arrhythmogenic right ventricular cardiomyopathy. Clin Genet 2011;80:256-64.
10. Beffagna G, Occhi G, Nava A, Vitiello L, DitadiA, BassoCet al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 2005;65:366-73.
11. Tiso N, StephanDA, Nava A, Bagattin A, Devaney JM, Stanchi F et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001; 10:189-94.
12. Otten E, Asimaki A, Maass A, Van Langen IM, Van der Wal A, De Jonge N et al. Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm 2010;7:1058-64.
13. Taylor M, GrawS, Sinagra G, Barnes C, Slavov D, Brun F et al. Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation 2011;124:876-85.
14. Quarta G, Syrris P, Ashworth M, Jenkins S, Zuborne Alapi K, Morgan J et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2012;33:1128-36.
15. Van der Zwaag PA, Van Rijsingen IAW, Asimaki A, Jongbloed JDH, Van Veldhuisen DJ, WiesfeldACP et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail 2012;14:1199-207.
16. Van Hengel J, Calore M, Bauce B, Dazzo E, Mazzotti E,DeBortoliMet al. Mutations in the area composita protein aT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2013;34:201-10.
17. Quarta G, Muir A, Pantazis A, Syrris P, Gehmlich K, Garcia-Pavia P et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation 2011;123:2701-9.
18. Ouyang P, Sugrue SP. Characterization of pinin, a novel protein associated with the desmosome-intermediate filament complex. J Cell Biol 1996;135:1027-42.
19. Joo J-H, Alpatov R, Munguba GC, Jackson MR, Hunt ME, Sugrue SP. Reduction of Pnn by RNAi induces loss of cell-cell adhesion between human corneal epithelial cells. Mol Vis 2005;11:133-42.
20. Joo J-H, Lee YJ, Munguba GC, Park S, Taxter TJ, Elsagga MY et al. Role of Pinin in neural crest, dorsal dermis, and axial skeleton development and its involvement in the regulation of Tcf/Lef activity in mice. Dev Dyn 2007;236:2147-58.
21. Goossens S, Janssens B, Bonné S,DeRycke R, Braet F, Van Hengel J et al.Aunique and specific interaction between alphaT-catenin and plakophilin-2 in the area composita, the mixed-type junctional structure of cardiac intercalated discs. J Cell Sci 2007;120: 2126-36.
22. Brennan D, Peltonen S, Dowling A, MedhatW, Green KJ,Wahl JK III et al. A role for caveolin-1 in desmoglein binding and desmosome dynamics. Oncogene 2012;31: 1636-48.
23. Hatzfeld M, Nachtsheim C. Cloning and characterization of a new armadillo family member, p0071, associated with the junctional plaque: evidence for a subfamily of closely related proteins. J Cell Sci 1996;109:2767-78.
24. Hatzfeld M, Green KJ, Sauter H. Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains. J Cell Sci 2003;116: 1219-33.
25. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 2000;14:704-18.
26. Ihrie RA, Bronson RT, Attardi LD. Adult mice lacking the p53/p63 target gene Perp are not predisposed to spontaneous tumorigenesis but display features of ectodermal dysplasia syndromes. Cell Death Differ 2006;13:1614-8.
27. Xu T, Yang Z, Vatta M, Rampazzo A, Beffagna G, Pilichou K et al. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2010;55:587-97.
28. Christensen AH, Benn M, Tybjærg-Hansen A, Haunso S, Svendsen JH. Screening of three novel candidate genes in arrhythmogenic right ventricular cardiomyopathy. Genet Test Mol Biomarkers 2011;15:267-71.
29. Campuzano O, Alcalde M, Berne P, Castro V, Guzzo G, Iglesias A et al. Genetic testing of candidate genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Med Genet 2012;55:225-34.